|
Valoración de DCF de Cocrystal Pharma, Inc. (COCP)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Cocrystal Pharma, Inc. (COCP) Bundle
¡Maximice la eficiencia y mejore la precisión con nuestra calculadora DCF (COCP)! Utilizando datos reales de Cocrystal Pharma, Inc. y supuestos personalizables, esta herramienta le permite proyectar, evaluar y valorar (COCP) al igual que un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.6 | 2.0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -69.32 | -100 | 0 | 0 | -42.33 | -42.33 | -42.33 | -42.33 | -42.33 |
| EBITDA | -47.9 | -9.3 | -13.8 | -38.4 | -19.4 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -729.68 | -461.97 | 100 | 100 | 100 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | .3 | .3 | .4 | .4 | -1.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 3.87 | 16.68 | 100 | 100 | 100 | 64.11 | 64.11 | 64.11 | 64.11 | 64.11 |
| EBIT | -48.2 | -9.6 | -14.2 | -38.8 | -18.0 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -733.55 | -478.65 | 100 | 100 | 100 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 7.4 | 33.0 | 58.7 | 37.1 | 26.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .6 | .6 | .0 | .7 | .9 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 9.81 | 27.61 | 100 | 100 | 100 | 67.48 | 67.48 | 67.48 | 67.48 | 67.48 |
| Inventories | .1 | .1 | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.76173 | 2.48 | 100 | 100 | 100 | 60.65 | 60.65 | 60.65 | 60.65 | 60.65 |
| Accounts Payable | 1.5 | .7 | .6 | .6 | 1.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 23.02 | 32.62 | 100 | 100 | 100 | 71.13 | 71.13 | 71.13 | 71.13 | 71.13 |
| Capital Expenditure | -.1 | -.2 | -.1 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -2.21 | -11.92 | 100 | 100 | 100 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -48.2 | -9.6 | -14.2 | -38.8 | -18.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -47.2 | -10.3 | -13.3 | -39.3 | -19.0 | -.3 | .0 | .0 | .0 | .0 |
| WACC, % | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 | 10.56 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -25 | |||||||||
| Equity Value | 24 | |||||||||
| Diluted Shares Outstanding, MM | 10 | |||||||||
| Equity Value Per Share | 2.51 |
What You Will Receive
- Pre-Filled Financial Model: Cocrystal Pharma's actual data allows for accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
- Instantaneous Calculations: Automatic updates provide immediate results as you make adjustments.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
- Customizable and Reusable: Designed for versatility, enabling repeated use for in-depth forecasts.
Key Features
- 🔍 Real-Life COCP Financials: Pre-filled historical and projected data for Cocrystal Pharma, Inc. (COCP).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Cocrystal Pharma’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Cocrystal Pharma’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file containing Cocrystal Pharma, Inc.’s (COCP) preloaded data.
- 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation scenarios.
- 5. Present with Assurance: Share professional valuation insights to reinforce your strategic decisions.
Why Choose This Calculator for Cocrystal Pharma, Inc. (COCP)?
- Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for Cocrystal Pharma.
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Cocrystal Pharma’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and consultants focused on biotech sectors.
Who Should Use This Product?
- Individual Investors: Make informed decisions regarding investments in Cocrystal Pharma, Inc. (COCP).
- Financial Analysts: Enhance valuation methodologies with comprehensive financial models tailored for Cocrystal Pharma, Inc. (COCP).
- Consultants: Provide clients with accurate and timely valuation insights related to Cocrystal Pharma, Inc. (COCP).
- Business Owners: Gain insights into the valuation of biotech firms like Cocrystal Pharma, Inc. (COCP) to inform your strategic planning.
- Finance Students: Explore real-world valuation techniques using data and scenarios from Cocrystal Pharma, Inc. (COCP).
What the Template Contains
- Historical Data: Includes Cocrystal Pharma’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Cocrystal Pharma’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Cocrystal Pharma’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.